UBS AM
MREO

UBS AM’s Mereo BioPharma MREO Stock Holding History

UBS AM’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,763,666
Closed -$735K – 3841
2025
Q4 		$735K Sell
1,763,666
-143,109
-8% -$272K ﹤0.01% 2235
2025
Q3 		$3.93M Buy
+1,906,775
New +$3.52M ﹤0.01% 1480
2025
Q2 		– Sell
-1,569,100
Closed -$3.53M – 2686
2025
Q1 		$3.53M Buy
1,569,100
+604,200
+63% +$1.71M ﹤0.01% 1735
2024
Q4 		$3.38M Buy
+964,900
New +$3.79M ﹤0.01% 1794

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return